AzTrials
AzTrials

Pain, ChronicNCT03023969

Implication of Two Doses of O2-O3 Upon the Pain Alleviation in Patients With Low Back Pain

A study testing ozone oxygen mixture in people with Pain, Chronic, run by Assiut University at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Low back pain is very common problem, variable modalities have been introduced to control such problem. One of the emerging modalities is the ozone - oxygen (O2-O3 ) mixture that could reduce the herniation disk size and inflammation. Read more about this study

Who is it for?
Ages 18 to 60 years
Conditions the study is for
Pain, Chronic
What is being tested?
ozone oxygen mixture
Type of treatment
Injection or infusion
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteEgypt
Study dates
Aug 2015to Dec 2016
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 60 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • All patients Suffered radicular leg pain and some reported additional back pain.
  • All patients are non-responsive to conservative treatment modalities with VAS more than 7.

Who cannot join

  • presence of bleeding disorder
  • local infection
  • uncontrolled or degenerative spine disease
  • pregnancy
  • multilevel disk involvement
  • patient refusal.

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Emad Zarief Kamel Said

    Asyut, Asyut Governorate, 71111

Other trials in Egypt

About this study

Official title: Implication of Two Different Doses of Intradiscal O2-O3 Injection Upon the Pain Alleviation in Patients With Low Back Pain: A Randomized, Single-blind Study

Low back pain is very common problem, variable modalities have been introduced to control such problem. One of the emerging modalities is the ozone - oxygen (O2-O3 ) mixture that could reduce the herniation disk size and inflammation.

Read the detailed description

Intervertebral disc herniation is the most common problem which induces low back pain LBP. The number of patients seek surgical and or alternative therapy increases. The rate of re-operation is between 7-9% at 2 years and increases up to 10-25% at ten years postoperative.

Epidural injections with local anesthetics and steroids are one of the most commonly used interventions in managing chronic low back pain and lower extremity pain of various causes. However, despite their extensive use, debate continues on this medications effectiveness due to the lack of well-designed, randomized, controlled studies to determine the effectiveness of epidural injections in general, and caudal epidural injections in particular.

Ozone in mixture with oxygen has been justified in multiple studies have been done, this study aims to evaluate variable doses of this mix upon patient satisfaction, pain alleviation over 12 month follow up period .

Conditions
Pain, Chronic
Being tested
ozone oxygen mixture
Medical subject headings
Chronic Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ozone oxygen mixtureDrug

    receive 10 ml of ozone oxygen mixture under variable dosing

Study groups in NCT03023969
Study groupRoleWhat they receive
group AActive comparatorpercutaneous ozone intradiscal injection group A receive 10 ml of ozone oxygen mixture 40 ug O3/ ml O2
Receives: Drug: ozone oxygen mixture
group BActive comparatorpercutaneous ozone intradiscal injection group receive 10 ml of ozone oxygen mixture 30 ug O3/ ml O2.
Receives: Drug: ozone oxygen mixture

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pain alleviation by visual analogue scale (VAS)

    assessing pain alleviation by visual analogue scale (VAS)

    Measured: 12 months

Secondary outcomes (2)
  1. Reduction of disk herniation by MRI

    evaluation of disk herniation by MRI 6 month after injection, in comparison to the pre-injection MRI

    Measured: 6 months

  2. Pain alleviation using Oswestry Low Back Pain Questionnaire

    using Oswestry Low Back Pain Questionnaire

    Measured: 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Jan 2017 (estimated)
  2. Study startAug 2015
  3. Primary completionDec 2016
  4. Study completionDec 2016

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
60 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03023969
Sponsor's protocol ID
IRB00009908
Status last verified
Feb 2017
First submitted
12 Jan 2017
Last updated
7 Feb 2017
Results posted
No
Data monitoring committee
No
Individual data sharing
Undecided

Publications

  • Elawamy A, Kamel EZ, Hassanien M, Wahba OM, Amin SE. Implication of Two Different Doses of Intradiscal Ozone-Oxygen Injection upon the Pain Alleviation in Patients with Low Back Pain: A Randomized, Single-Blind Study. Pain Physician. 2018 Jan;21(1):E25-E31.

    PubMed 29357333

Questions about this trial

What is this clinical trial studying?

A study testing ozone oxygen mixture in people with Pain, Chronic, run by Assiut University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 7 Feb 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pain alleviation by visual analogue scale (VAS) (time frame: 12 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03023969, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Feb 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in